What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall affecting Levothyroxine Sodium Tablets, USP, specifically the 175 mcg (0.175 mg) strength. This medication is manufactured by Accord Healthcare, Inc., a company based in Raleigh, North Carolina, though the physical production took place at Intas Pharmaceuticals Limited in Selaqui, Dehradun, India. The scope of this recall is significant because it impacts two distinct packaging formats distributed nationwide across the United States. Consumers should be aware that the affected items are prescription-only drugs, meaning they were dispensed through pharmacies based on a doctor’s order, rather than sold over-the-counter in general retail stores.
The first category of recalled product consists of Levothyroxine Sodium Tablets, USP, 175 mcg, packaged in 90-count bottles. These specific units are identified by the National Drug Code (NDC) 16729-456-15. The second category includes the same medication strength but is packaged in larger, bulk-sized 1000-count bottles, identified by NDC 16729-456-17. It is crucial to check both the bottle size and the NDC number when verifying your inventory, as the recall does not necessarily apply to all Accord Healthcare Levothyroxine products, only those matching these specific packaging profiles.
To determine if you possess a recalled item, you must look closely at the lot numbers and expiration dates printed on the packaging. For the 90-count bottles (NDC 16729-456-15), the recall applies exclusively to Lot # D2402642, which has an expiration date of November 30, 2026. For the 1000-count bottles (NDC 16729-456-17), the situation is more complex as multiple lots are involved. The affected lot numbers for this larger package size include D2401832 (expiration date August 31, 2026), as well as six additional lots: D2402525, D2402527, D2402526, D2402644, and D2402643. All of these latter lots also share the expiration date of November 30, 2026. If your bottle matches any of these lot numbers and NDCs, it is part of this nationwide distribution and should be handled according to safety guidelines.
The recall was officially announced on August 6, 2026. At that time, Accord Healthcare identified that the product failed to meet its labeled potency specifications. While the exact volume of units sold is not detailed in the public record, the fact that these items were distributed nationwide suggests a wide reach. Because Levothyroxine is a hormone replacement therapy often taken daily for thyroid management, even a small percentage of subpotent doses can have clinical implications for patients relying on consistent dosage levels. If you are unsure whether your specific bottle is affected, please compare the lot number and NDC on your current supply against the list provided above.
The hazard, explained
At the heart of this recall is a subtle but potentially serious issue known as a subpotent drug classification. In plain terms, this means that the Levothyroxine Sodium Tablets in question likely contain less of the active ingredient than the label claims. Levothyroxine is a synthetic version of thyroxine (T4), a hormone naturally produced by your thyroid gland. This hormone acts as a master regulator for your metabolism, influencing how your body uses energy, how fast your heart beats, and even how your brain functions. Because it plays such a critical role in maintaining your body’s internal balance, the margin for error is incredibly small.
When a drug is subpotent, the physical mechanism of failure usually lies in the manufacturing or chemical stability process. It may result from an incomplete reaction during synthesis, improper mixing of ingredients, or degradation of the compound over time due to environmental factors like heat or humidity during storage or transport. In this specific case involving Accord Healthcare, Inc., the 175 mcg strength tablets are suspected of not delivering the full dose your body expects. While a slight variation might be tolerable for some medications, thyroid hormone replacement therapy is notoriously sensitive. The relationship between the dose and its effect on your body is steep and precise; a small drop in potency can lead to a disproportionately large drop in therapeutic effect.
This lack of potency translates directly into untreated hypothyroidism. Your body relies on a consistent level of thyroid hormone to keep your metabolic engine running correctly. When the drug fails to provide the necessary dosage, your metabolism may slow down significantly. This isn't just about feeling tired; it is a systemic shutdown. Symptoms can include severe fatigue, unexplained weight gain, sensitivity to cold, constipation, dry skin, and hair loss. More critically, prolonged untreated hypothyroidism can elevate cholesterol levels, increasing the risk of heart disease, and in extreme cases, lead to myxedema, a rare but life-threatening condition characterized by lethargy, unconsciousness, and hypothermia.
The danger here is compounded by the fact that these symptoms often develop gradually. You might not realize your medication has stopped working effectively until significant changes have occurred in your health. Because thyroid levels are managed through blood tests that monitor TSH (Thyroid Stimulating Hormone) levels, a subpotent drug can cause your TSH to rise dangerously high while you remain unaware that the root cause is inadequate medication strength rather than a new underlying disease process. This recall highlights why precise dosing in endocrinology is not just a matter of convenience, but a critical component of safe medical management.
Who is most at risk
When we talk about who is most at risk from this specific recall, we are looking at two distinct groups: those who currently possess the affected medication and those whose health depends on precise hormonal balance. The primary group at immediate risk consists of individuals who have purchased or been prescribed Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) manufactured by Accord Healthcare, Inc. Specifically, this includes anyone holding bottles with National Drug Codes (NDC) 16729-456-15 (90-count) or NDC 16729-456-17 (1000-count). If you have these medications in your cabinet, particularly those with lot numbers D2402642, D2401832, D2402525, D2402527, D2402526, D2402644, or D2402643, you are directly in the circle of concern. Because this distribution was nationwide, the risk is not localized; it exists wherever these specific lots were dispensed by pharmacies across the United States.
Beyond mere possession, the physiological vulnerability lies with patients who rely on Levothyroxine to manage hypothyroidism—a condition where the thyroid gland does not produce enough thyroid hormone. This drug is a synthetic form of thyroxine (T4), and its primary job is to restore normal thyroid levels in the body. For most people, small fluctuations are manageable, but for others, precision is critical. The hazard identified in this recall is that the drug is "subpotent," meaning it contains less active ingredient than what is labeled. Even a slight reduction in dosage can lead to a drop in circulating thyroid hormone levels, effectively reversing the treatment’s benefits.
While anyone with hypothyroidism taking this specific strength could be affected, certain demographics face heightened risks due to how their bodies process medication and manage stress. Elderly patients, for instance, often have more sensitive cardiovascular systems. Thyroid hormone has a direct impact on heart rate and contractility; if the dosage is unexpectedly low, it can exacerbate underlying heart conditions or lead to fatigue and weakness that increases the risk of falls. Furthermore, older adults may already be managing multiple medications, making any change in efficacy harder to detect immediately.
Pregnant individuals or those planning pregnancy are another critical group. Thyroid hormone is essential for fetal brain development, especially in the first trimester. Even minor deviations in maternal thyroid levels can have significant implications for both mother and child. Similarly, patients with severe hypothyroidism who are on the higher end of the dosage spectrum (like the 175 mcg strength) may be more sensitive to changes because they require a substantial replacement dose. For these individuals, the "subpotent" nature of this batch could mean a return of serious symptoms such as profound fatigue, weight gain, cold intolerance, and depression, which might be mistaken for other ailments rather than a medication failure. Therefore, it is not just about who has the bottle, but whose health trajectory is most tightly coupled to the exact potency of their daily dose.
How to tell if you have the recalled item
When dealing with a pharmaceutical recall, particularly one involving a medication as critical as levothyroxine sodium, relying on visual cues alone is not enough. While it can be tempting to check the bottle’s color or shape, these features often remain consistent across different manufacturing lots and expiration dates. Therefore, the only reliable way to determine if your medication is part of this specific recall is to examine the printed lot number and expiration date located directly on the packaging. You must cross-reference these two pieces of information against the official FDA recall data for Accord Healthcare, Inc.
First, ensure you have the correct product. The recall specifically targets Levothyroxine Sodium Tablets, USP, in a strength of 175 mcg (0.175 mg). You should look for bottles manufactured by Accord Healthcare, Inc., with their address listed as Raleigh, NC 27617, and manufactured by Intas Pharmaceuticals Limited in India. The product is available in two specific package sizes: 90-count bottles with National Drug Code (NDC) 16729-456-15, and 1000-count bottles with NDC 16729-456-17. If your bottle does not match these NDCs or the specified strength, it is likely not part of this specific recall action.
The most critical step is checking the lot numbers. You must look at the label on either the outer carton or the bottle itself for the "Lot #" or "LOT" designation. The following specific lot numbers are included in this Class II recall due to being subpotent:
- D2402642: This lot has an expiration date of 11/30/2026.
- D2401832: This lot has an expiration date of 08/31/2026.
- D2402525, D2402527, D2402526, D2402644, and D2402643: All of these lots have an expiration date of 11/30/2026.
If your medication matches any of the lot numbers listed above, you should consider it potentially affected by this recall. It is important to note that even if your expiration date appears far in the future, the chemical potency may still be below the required standard due to manufacturing issues. Do not rely on the expiration date as a primary identifier; the lot number is the definitive key. If you cannot find the lot number clearly printed on the bottle or box, or if the label is worn and illegible, it is safest to contact your pharmacy or the manufacturer for assistance in verifying the product details.
What to do — step by step
If you have been taking Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) manufactured by Accord Healthcare, Inc., the first and most important thing to understand is that this recall involves a "subpotent" drug. This means the medication may not contain enough of the active ingredient to effectively treat your condition. Because thyroid hormone replacement is highly precise and critical for regulating your metabolism, heart rate, and energy levels, you should not simply wait to see if the medicine works. Instead, you need to take immediate, structured action to ensure your health remains stable during this transition.
- Stop taking the specific recalled lots immediately. Check your bottle against the recall details provided by the FDA. You are dealing with NDC 16729-456-15 (90-count bottles) and NDC 16729-456-17 (1000-count bottles). The affected lots include D2402642, D2401832, D2402525, D2402527, D2402526, D2402644, and D2402643. If your bottle matches these lot numbers, set it aside in a safe place where you will not accidentally take another dose.
- Contact your healthcare provider or pharmacist right away. Do not wait for your next scheduled appointment. Call your doctor’s office or your local pharmacy to inform them that you have recalled medication on hand. Ask them for a new prescription filled with product from a different manufacturer or a different lot number that is confirmed to be safe. It is vital that you do not experience any gap in your thyroid hormone coverage, as even a short interruption can lead to significant symptoms like fatigue, weight gain, and mood changes.
- Determine how to dispose of or return the recalled product. Here is where we must be honest about the information available: The official FDA recall notice for this Accord Healthcare batch does not explicitly state a specific remedy such as "return to store" or "request a refund." Because the manufacturer has not published clear instructions on the disposition of these subpotent tablets, you should not attempt to sell them or give them to others. Do not flush them down the toilet unless local guidelines strictly permit it for this specific drug. Instead, take the sealed bottles to a pharmacy that offers a medication take-back program, or follow your local community’s hazardous waste disposal instructions. Your pharmacist can guide you on the safest, legal way to destroy these pills so they do not enter the water supply or be accessed by children or pets.
- Monitor your body for changes. Because the drug is subpotent, you may notice a return of hypothyroid symptoms such as unusual tiredness, sensitivity to cold, dry skin, or constipation. Keep a simple log of how you feel over the next few days. If you experience severe weakness, confusion, or other concerning symptoms after stopping the medication, seek medical attention promptly. Your doctor may need to adjust your dosage temporarily with a different brand to bridge the gap until your new prescription is fully active.
While this process might feel like a hassle, it is a standard safety procedure in pharmaceutical recalls. The priority here is ensuring you have reliable medication from a verified source. By contacting your provider immediately and safely discarding the recalled product, you protect your long-term health while the regulatory authorities handle the investigation into why the potency was affected.
Your refund, repair, or replacement options
When a medication recall occurs, the most immediate concern for patients is often how to handle the specific product they have purchased and what financial or logistical steps are required to resolve the situation. In this instance, Accord Healthcare, Inc. has initiated a Class II recall of Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg). It is important to approach the remedy process with clarity and patience. The official recall notice provided by the FDA for this specific event does not explicitly state the detailed remedy terms, such as whether a direct refund is issued, or if the company will provide a replacement dose at no cost. Because Levothyroxine is a critical hormone replacement medication used to treat hypothyroidism, the lack of a stated "repair" option (which is common with drugs) means your primary focus should be on obtaining a safe, non-recalled supply and understanding your rights regarding the subpotent product you may currently possess.
Since the recall involves products manufactured for Accord Healthcare, Inc., located in Raleigh, NC, and distributed nationwide, the standard procedure for consumers typically involves contacting the point of purchase or the distributor directly. If you purchased these bottles from a retail pharmacy, your first step should be to return the unused portion of the medication to the pharmacy counter. Pharmacists are trained to handle recall protocols; they will likely quarantine the product and process a credit or refund to your original payment method in accordance with their store’s policy. It is highly advisable to keep your receipt or proof of purchase handy, as this will expedite the reimbursement process. If you ordered the medication through an online retailer, you should initiate a return through their customer service portal, citing the specific NDC (National Drug Code) 16729-456-15 for the 90-count bottles or NDC 16729-456-17 for the 1000-count bottles to ensure the return is correctly logged.
If you are currently taking this medication and have not yet finished your bottle, do not stop taking it abruptly without consulting your healthcare provider. However, you must verify if your specific lot number is part of the recall. The affected lots include D2402642 (expiring 11/30/2026), D2401832 (expiring 08/31/2026), and several others expiring in November 2026. If your bottle matches these numbers, you need to transition to a safe supply immediately. Contact your prescribing physician or pharmacist right away to discuss obtaining a new prescription from a different manufacturer or lot that is not part of this recall. While the recall notice does not specify if Accord Healthcare will send free replacements directly to consumers, healthcare providers often have direct lines to manufacturers to facilitate urgent patient care during such events. They may be able to source non-recalled inventory for you quickly.
In summary, while the official document does not outline a specific "refund or replacement" program managed by Accord Healthcare for individual patients, your financial recourse lies primarily with the retailer where you made the purchase. For health safety, your priority is securing an equivalent dose from a different, verified source. Always confirm with your pharmacist that any new supply you receive has a lot number not listed in this recall to ensure you are receiving full-strength medication as prescribed.
What can happen if you ignore it
When a medication like levothyroxine is recalled for being subpotent, the immediate danger isn't always a sudden crisis, but rather a slow, insidious shift in your body’s chemistry. Levothyroxine is not just another supplement; it is a hormone replacement therapy that does critical work every single day. It regulates your metabolism, heart rate, body temperature, and energy levels. Because the medication in question contains less of the active ingredient than it should, your body is essentially receiving fewer instructions than it needs to function correctly. If you continue to take these tablets without realizing they are compromised, you are effectively allowing hypothyroidism to return or worsen, even if your condition was previously under control.
The consequences of ignoring this issue can ripple through your entire physical and mental well-being. On a physiological level, your metabolism may begin to slow down significantly. This isn't just about feeling tired; it is about your heart working harder to pump blood, your body struggling to maintain warmth, and your digestive system slowing to a crawl. You might notice unexplained weight gain, persistent constipation, or a feeling of coldness when others are comfortable. These are not minor inconveniences; they are signs that your vital organ systems are not getting the hormonal support they require to operate safely.
Mental and cognitive effects can be equally impactful. Many people with untreated or under-treated thyroid conditions report "brain fog," difficulty concentrating, memory lapses, and a deep, unshakable fatigue that sleep does not fix. In some cases, depression or anxiety symptoms can emerge or intensify because the brain is not receiving adequate thyroid hormone to regulate neurotransmitters. For older adults or those with pre-existing heart conditions, the stakes are even higher. An underactive thyroid puts extra strain on the cardiovascular system, potentially leading to elevated cholesterol levels and increased risk of heart-related complications over time.
It is also important to understand that levothyroxine has a very narrow therapeutic index. This means the difference between a helpful dose and an ineffective one is quite small. A subpotent drug creates a gap in your treatment plan that can be difficult to close quickly once discovered. If you ignore the recall, you are not just delaying a refill; you are allowing your body’s baseline health to drift downward. The longer you wait, the more symptoms may accumulate, potentially leading to more complex medical issues that require additional intervention to reverse. Your best course of action is to stop using the recalled lots immediately and consult your healthcare provider to discuss safe alternatives or monitoring steps.
Staying safe: broader tips
While specific recalls are necessary when manufacturing inconsistencies occur, maintaining long-term medication safety relies on proactive habits and a clear understanding of how to manage your prescriptions. Because Levothyroxine is a hormone replacement that requires precise dosing to regulate metabolism, heart rate, and energy levels, the stakes for accuracy are high. General best practices for managing any critical prescription medication begin with rigorous organization. Keep all your medications in their original containers with visible labels. This simple step ensures you always have access to the exact strength, manufacturer, and expiration date, which are the first things you must verify if a recall is announced. Avoid transferring pills into daily organizers unless absolutely necessary, as this can lead to confusion about dosages or loss of critical label information.
Another vital layer of protection is staying informed without waiting for a crisis. Sign up for email alerts from the U.S. Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS). These agencies issue notifications when new risks are identified, allowing you to act before a situation becomes urgent. Additionally, check with your pharmacist regularly. Pharmacists are medication experts who track national supply chains and can often identify if your specific pharmacy has received lots from a manufacturer that may be subject to future warnings or quality checks.
When it comes to storage, environmental factors can degrade even high-quality drugs over time. Levothyroxine, like many other medications, is sensitive to moisture, heat, and light. Store your tablets in a cool, dry place away from direct sunlight—never in the bathroom medicine cabinet where steam and temperature fluctuations are common. Proper storage helps maintain the drug’s potency until its expiration date, ensuring that you receive the full therapeutic benefit of each dose.
Finally, never adjust your dosage or stop taking your medication abruptly due to a recalled lot without consulting your healthcare provider. If you possess a recalled item, return it as instructed by the manufacturer or pharmacist. In the interim, your doctor can help you obtain a replacement from a different manufacturer or lot that meets safety standards. Consistent communication with your healthcare team ensures that your treatment plan remains uninterrupted and effective, regardless of supply chain issues. By combining vigilance with proper storage and open dialogue with your providers, you take control of your health outcomes.